Group 1 - The core viewpoint of the articles highlights the comprehensive reform of the medical insurance system in 2026, focusing on payment methods, centralized procurement, and price management to enhance fund utilization and reduce the burden on patients [1][2] Group 2 - The optimization of medical insurance payment methods will include the implementation of a dynamic adjustment mechanism for Diagnosis-Related Group (DRG) and Disease-Related Group (DIP) payment systems, alongside the introduction of a 3.0 version plan [1] - The reform will also support the development of traditional Chinese medicine and other ethnic medical services by establishing appropriate payment policies [1] - The centralized procurement of medicines will be expanded to include national procurement of traditional Chinese medicine pieces and joint procurement of ethnic medicines, ensuring that quality and affordable products are prioritized in medical institutions [2] Group 3 - A dynamic adjustment mechanism for medical service prices will be implemented to better reflect the value of medical personnel's technical services [2] - The establishment of a "green channel" for regional medical centers regarding project pricing and medical insurance access aims to promote the distribution of quality medical resources [2] - The introduction of the "medical insurance drug cloud platform" will enhance price monitoring and management of drugs in retail pharmacies, creating a new ecosystem for medical insurance drug services [2]